Risedronic acid - AbbVie
At a glance
- Drug Originator Procter & Gamble
- Drug Licenced by Ajinomoto; Almirall S.A.; Eisai Co Ltd; Laboratorios Beta; Sanofi; Takeda; The Alliance for Better Bone Health
- Drug Class Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
- Mechanism of Action Bone resorption factor inhibitors; HMG-CoA reductase inhibitors
- USA Patent Applicants APIL
- USA Patents 18
- NDAs 2
- International Patents 155
- Patent Applications 6,150

Disclaimer